 The purpose of the study is to understand if there is benefit in continued treatment with a medicine called enzalutamide, when starting treatment with docetaxel and prednisolone a standard chemotherapy for prostate cancer, after the prostate cancer has gotten worse when treated with enzalutamide alone. 